Physician

Michael James De Luca, MD

According to 2025 Medicare claims, Michael Luca, MD (NPI: 1053311936) practices internal medicine in the El Paso, TX market, with the plurality of this provider's patient population coming from El Paso, TX. This provider's primary affiliated billing organization is EL PASO CARDIOLOGY ASSOCIATES, P.A. (NPI: 1235294232; TIN: 742844275) and primary practice location at 79912-3508.

Luca's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 758 traditional Medicare patients, billed 8,079 HCPCS/CPT codes, and received $862,249 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 9,124 prescription claims across 1,329 beneficiaries totaling $1,224,736 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 106 claims. Open Payments data shows 41 records totaling $577. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $396,354 to $862,249. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $482,113 to $1,224,736. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $7,324 and ending at $12,845.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	990	6,717	$396,354
2016	1,121	14,775	$631,961
2017	1,247	18,478	$773,280
2018	1,080	17,940	$757,379
2019	981	16,110	$916,046
2020	852	12,590	$849,552
2021	801	13,549	$958,841
2022	788	9,394	$752,055
2023	747	8,130	$773,020
2024	758	8,079	$862,249

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,022	8,432	$482,113
2016	977	6,825	$415,380
2017	1,042	6,798	$474,449
2018	1,155	7,457	$566,285
2019	1,272	7,940	$777,175
2020	1,294	9,049	$937,542
2021	1,368	9,310	$1,095,847
2022	1,342	9,099	$1,166,809
2023	1,294	8,943	$1,164,631
2024	1,329	9,124	$1,224,736

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	73	$3,018
2016	N/R	26	$1,224
2017	N/R	30	$30,133
2018	N/R	90	$3,652
2019	N/R	152	$10,676
2020	N/R	146	$9,838
2021	N/R	106	$7,402
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	276	282	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	685	1,549	$85
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	203	205	$50
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	481	512	$10
J2785	Injection, regadenoson, 0.1 mg	183	736	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	497	31,388	$606,822
Xarelto	Rivaroxaban	240	16,030	$299,543
Brilinta	Ticagrelor	57	3,630	$54,021
Entresto	Sacubitril/Valsartan	36	2,280	$46,695
Multaq	Dronedarone Hcl	14	1,080	$22,498

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	41	$577	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael James De Luca, MD?

Tedicare shows public-source Medicare data for Michael James De Luca, MD (NPI 1053311936), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael James De Luca, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael James De Luca, MD?

Michael James De Luca, MD is linked to EL PASO CARDIOLOGY ASSOCIATES, P.A. (billing NPI 1235294232) in the available physician profile data.

Does Michael James De Luca, MD have Open Payments data?

Michael James De Luca, MD has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.